» Articles » PMID: 37417806

Evaluation of Functional and Joint Health and Associated Factors in Adults With Hemophilia From a Developing Country With Government-Backed Efforts to Improve Hemophilia Care

Abstract

Introduction Hemophilic arthropathy affects people with hemophilia (PwH) and causes joint dysfunction and disability. Brazil has a unique situation and implemented policies to improve health care for PwH. The aim of this study was to evaluate the Functional Independence Score in Hemophilia (FISH), Hemophilia Joint Health Score (HJHS), and associated factors among adult PwH attending a Hemophilia Comprehensive Care Center in Brazil. Methods A post hoc analysis was conducted, including 31 patients who had submitted to a physical evaluation during a previously published cross-sectional study performed from June 2015 to May 2016 at the Brasília Blood Center Foundation, Brazil. Results The mean age was 30.8±9.4 years, and 80.6% had severe hemophilia. FISH was 27.0±3.8, and HJHS 18.0±10.8. The ankle was the most often affected joint (25/31, 80.6%). There were significant correlations between FISH and HJHS scores and the Hemophilia Quality of Life Questionnaire for Adults. Patients with severe hemophilia ( = 0.029) and PwH aged ≥ 30 years ( = 0.049) had lower FISH scores. Monthly household income > 2 Brazilian minimum wages was independently associated with improved HJHS ( = 0.033). The factors simultaneously associated with better HJHS and FISH were age < 30 years ( = 0.021) and monthly household income < 2 minimum wages ( = 0.013). Conclusion FISH and HJHS showed favorable scores despite being performed in a country with unfavorable socioeconomic conditions. In addition to hemophilia severity and age, monthly household income was independently associated with functional and articular state of PwH. The results highlight the importance of the free provision of coagulation factors in Brazil.

Citing Articles

Serum Vitamin D in Children with Hemophilia A and Its Association with Joint Health and Quality of Life.

Salem A, AbdEltwwab T, Moawad H, Elgendy M, Al-Fakharany R, Khames A Hematol Rep. 2024; 16(4):742-751.

PMID: 39728001 PMC: 11727777. DOI: 10.3390/hematolrep16040071.

References
1.
Manco-Johnson M, Abshire T, Shapiro A, Riske B, Hacker M, Kilcoyne R . Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007; 357(6):535-44. DOI: 10.1056/NEJMoa067659. View

2.
Kachooei A, Badiei Z, Zandinezhad M, Ebrahimzadeh M, Mazloumi S, Omidi-Kashani F . Influencing factors on the functional level of haemophilic patients assessed by FISH. Haemophilia. 2013; 20(2):185-9. DOI: 10.1111/hae.12273. View

3.
Barr R, Saleh M, Furlong W, Horsman J, Sek J, Pai M . Health status and health-related quality of life associated with hemophilia. Am J Hematol. 2002; 71(3):152-60. DOI: 10.1002/ajh.10191. View

4.
Oldenburg J . Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. Blood. 2015; 125(13):2038-44. DOI: 10.1182/blood-2015-01-528414. View

5.
Soares B, Simeoni L, de Almeida K, de Souza J, Imoto A, Braverman M . Factors Associated with Compliance with the Treatment Protocol and Mortality in Adults with Hemophilia. Patient Prefer Adherence. 2020; 14:2279-2285. PMC: 7691649. DOI: 10.2147/PPA.S279401. View